Stock Ticker

  • Loading stock data...

The Fast-Track Status of Hemophilia A Drug By Sangamo Therapeutics Inc (NASDAQ:SGMO) Inspires Great Hope, Sources Say

Sangamo Therapeutics Inc (NASDAQ:SGMO) has moved ahead to make an announcement regarding the move to grant fast-track designation to pipeline candidate, SB-525.,something that has sparked high talk among all the concerned parties. According to some top financial officers working with the provider, it has been revealed that Sangamo’s shares declined 145.9% year to date. A […]

Pharmacyte Biotech Inc (OTCMKTS:PMCB) And Growblox Sciences Inc (OTCMKTS:GBLX) Trades In A Narrow Range

Pharmacyte Biotech Inc (OTCMKTS:PMCB) declined 0.52% and closed at $0.0959 in last trading session. The biotech firm is still in clinical stage and it is working to develop targeted therapies to treat diabetes and cancer based on Cell-in-a-Box® technology. Recently, the COO of Pharmacyte, Dr. Gerald W. Crabtree, Ph.D. highlighted company’s development plans in an […]

Sangamo Biosciences, Inc. (NASDAQ:SGMO) Up On This Reason

Boston, MA 03/07/2014 (wallstreetpr) – Sangamo Biosciences, Inc. (NASDAQ:SGMO) was one of the biotech movers in the last session. It was nice to see shares swing to new price records as investors betted on the prospects of the stock. But what exactly are the prospects, one may ask? The company is concerned with among other […]